By Mill Chart
Last update: Nov 7, 2025
Technical investors often look for stocks showing both good existing momentum and attractive buying opportunities. The breakout method used here finds securities with sound technical condition using ChartMill's own Technical Rating, paired with consolidation patterns measured by the Setup Quality Rating. This two-part rating system helps separate equities that are not only moving upward but are also creating foundations from which a clear price move might develop. Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) recently appeared from a screen searching for these particular traits, offering an example of this approach at work.

A basic part of a workable breakout candidate is a good and continuing upward price direction. The ChartMill Technical Rating, which examines items such as relative strength and moving averages over several periods, tries to measure this condition. Crinetics Pharmaceuticals displays a firm technical base, as described in its full technical report.
Important technical measures for CRNX include:
This combined technical condition is important for the method because it implies the stock has the existing momentum needed to possibly maintain a breakout move, instead of one that might fail quickly.
While a good trend is needed, it is not enough for a best purchase. A high Setup Quality Rating finds times of price stabilization, where price movement tightens and the stock forms a base, giving a cleaner risk-reward situation. CRNX gets a very high 9 out of 10 in this area.
The present situation for CRNX is described by a number of positive factors:
This stabilization stage is exactly what the breakout method looks for. It allows for a planned purchase point just above resistance, with a well-defined stop-loss below support, efficiently controlling the trade's risk from the start.
The automatic examination of CRNX's chart proposes a possible trading situation with a purchase point set just above a resistance level at $43.99. This buy-stop instruction would only activate if the stock price confirms the breakout by moving above this level. The suggested exit, or stop-loss, is positioned at $42.77, just below the closest support area. This framework contains the estimated risk on the trade to about 2.8%.
It is important to mention that while the S&P 500's short-period trend is positive, CRNX is presently trading in the middle of its 52-week band. This shows that the stock is not overly stretched and might have space to rise if the breakout works, separate from the wider market's neutral long-period trend.
The approach that found Crinetics Pharmaceuticals can be used in a regular way to discover new possible breakout candidates every day. Investors searching for an updated list of stocks displaying high technical and setup ratings can review the present outcomes by visiting the Technical Breakout Setups screen.
Disclaimer: This examination is based on technical information and automatic scoring models and is for educational reasons only. It is not a suggestion to purchase or sell any security. All investments carry risk, and you should do your own investigation and think about your individual financial condition before making any investment choices. The given trade situation is an automatic illustration and does not make up investment advice.
NASDAQ:CRNX (12/4/2025, 12:48:06 PM)
48
+1.02 (+2.17%)
Find more stocks in the Stock Screener


